Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of Medication Utilization and Expenses for Respiratory Care Under Colombia's 2022 Health Benefit Plan

  • By

  • Manuel Enrique Machado-Duque

  • Luis Fernando Valladales-Restrepo

  • Andrés Gaviria-Mendoza

  • Juan Pablo Albanes-Beltrán

  • Giovanny Mesa-Escobar

  • Ana Camila Delgado-Araujo

  • María Camila Oyuela-Gutiérrez

  • Santiago Rubio-Londoño

  • Jorge Enrique Machado-Alba

  • September 14, 2026

Share

  • 1

    Colombia's 2022 Health Benefit Plan expanded coverage for respiratory therapies, adding long-acting bronchodilators and monoclonal antibodies.

  • 2

    Prior to the update, the plan primarily included short-acting bronchodilators and inhaled corticosteroids for respiratory conditions.

  • 3

    The study analyzed medication utilization and costs for newly included respiratory medications from January 2021 to June 2023.

  • 4

    The update aimed to address gaps in first-line therapies for asthma and COPD, reflecting changes in prescribing practices.

  • 5

    The inclusion of new therapies may increase medication consumption and associated costs for patients under Colombia's health system.

Original Source(s)

Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System

  • by Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Andrés Gaviria-Mendoza, Juan Pablo Albanes-Beltrán, Giovanny Mesa-Escobar, Ana Camila Delgado-Araujo, María Camila Oyuela-Gutiérrez, Santiago Rubio-Londoño, Jorge Enrique Machado-Alba

  • September 14, 2026

Related Content

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Oral Microbiome Richness Tied to CRS

A cross-sectional metagenomic study found greater oral microbiome richness among adults with chronic rhinosinusitis, particularly nonallergic chronic rhinosinusitis, while associations with asthma, airway inflammation, and most lung-function measures were inconsistent.

Tree Canopy Gains Linked to Lower Mortality

The association was most pronounced in Chicago’s hottest neighborhoods, where canopy losses were linked to higher predicted mortality.